MediPharm Makes History: Supplying Cannabis Oil for US Clinical Trial Through Cross-Border Export
Canadian marijuana producer, MediPharm Labs, announced the successful completion of a shipment of cannabis oil containing both CBD and THC to the United States. The purpose of this shipment is for use in a clinical trial.
In an exciting development, MediPharm recently announced a groundbreaking milestone.
For the first time ever, a cannabis product sourced from a licensed Canadian producer is being utilized in a Phase 2 clinical trial in the United States.
This highlights the growing acceptance and recognition of cannabis for scientific purposes and underscores the increasing collaboration between industry leaders across borders.
In a news release, MediPharm said the export process relied on:
Its Drug Establishment License and product stability data.
The United States’ Innovative New Drug Approval.
U.S. Drug Enforcement Administration import approval.
MediPharm said steps to meet those requirements were years in the making and involved significant capital investments.
“This development is significant as the majority of cannabis operators in the US are operating under state specific regulations that prohibits them from manufacturing for FDA sanctioned research activities and DEA approved shipments under federal narcotic laws,” MediPharm’s release noted.
Read more here.
If you’re interested in growing your cannabis business with cannabis digital marketing and CBD SEO, contact our cannabis marketing agency today.
